Quantification of Interstitial Fibrosis by Image Analysis on Routine Renal Biopsy in Patients Receiving Cyclosporine

Background. Renal interstitial fibrosis (IF) is the main histopathological feature of chronic allograft injury. IF is currently assessed by semiquantitative analysis, but automatic color image analysis may be more reliable and reproducible. We performed a retrospective analysis to calculate IF on routine renal biopsies performed at 1 year posttransplant. Methods. Data were obtained from MO2ART, a prospective multicenter trial in which cyclosporine A dose was adjusted based on C2 level. One-year routine biopsies were assessed from 26 patients from two centers. For each biopsy, a section was analyzed by a program of color segmentation imaging, which automatically extracts green color areas characteristic of IF. Results were expressed as percentage of IF and grade (grade 1: <25%, grade 2: 25–50%, and grade 3: >50%). Results. Mean IF score was 0.35±0.04. Quantitative IF grade 1 was observed in 9 biopsies (34.6%), grade 2 in 12 (46.1%), and grade 3 in 5 (19.2%). Diabetes and cytomegalovirus infection were significantly associated with a higher percentage of IF. There was no correlation between the group of randomization and IF. We found a statistical significant correlation between Banff 05 chronic lesions classification and the IF index (P<0.02). Repeated analysis of variance demonstrated an association between high grade of automated IF and a worsening of creatinine clearance (Modification of Diet in Renal Disease) between 1 and 3 years. Conclusions. Automatic quantification of IF on routine renal biopsies at one year posttransplant is predictive of long-term allograft function and may assist early diagnosis of the interstitial lesions of chronic allograft injury.

[1]  E. Condom,et al.  Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. , 2000, Transplantation.

[2]  J. D. de Fijter,et al.  Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. , 2006, Journal of the American Society of Nephrology : JASN.

[3]  J. Chapman,et al.  Delta Analysis of Posttransplantation Tubulointerstitial Damage , 2004, Transplantation.

[4]  C. Cardella,et al.  Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients1 , 2003, Transplantation.

[5]  P. Nickerson,et al.  Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  F. Moreso,et al.  Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. , 2002, Kidney international.

[7]  G. Mazariegos,et al.  Dendritic Cell Subset Ratio in Tolerant, Weaning and Non‐Tolerant Liver Recipients Is Not Affected by Extent of Immunosuppression , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  N Taub,et al.  International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project. , 2001, Kidney international.

[9]  F. Moreso,et al.  Serial Protocol Biopsies to Quantify the Progression of Chronic Transplant Nephropathy in Stable Renal Allografts , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  N. Marcussen,et al.  Reproducibility of the Banff classification of renal allograft pathology. Inter- and intraobserver variation. , 1995, Transplantation.

[11]  S. Dodd.  Chronic allograft nephropathy: the inevitable outcome of renal transplantation? , 1999, Current topics in pathology. Ergebnisse der Pathologie.

[12]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[13]  H. E. Hansen,et al.  The Banff 97 working classification of renal allograft pathology. , 1999, Kidney international.

[14]  M. Sarwal,et al.  A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[15]  D. Heisey,et al.  Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. , 1999, Transplantation.

[16]  D. Goldfarb,et al.  The natural history of chronic allograft nephropathy. , 2005, The Journal of urology.

[17]  J. Ehrich,et al.  Renal arterial resistance index and computerized quantification of fibrosis as a combined predictive tool in chronic allograft nephropathy , 2004, Pediatric transplantation.

[18]  E. Condom,et al.  Early protocol renal allograft biopsies and graft outcome. , 1997, Kidney international.

[19]  S. Chadban,et al.  Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion , 2003, Transplantation.

[20]  T. Hovig,et al.  Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  J. D. de Fijter,et al.  No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. , 2005, Journal of the American Society of Nephrology : JASN.

[22]  S. Chadban,et al.  Efficacy and Safety Outcomes Among De Novo Renal Transplant Recipients Managed by C2 Monitoring of Cyclosporine A Microemulsion: Results of a 12-Month, Randomized, Multicenter Study , 2005, Transplantation.

[23]  P. Nickerson,et al.  Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. , 1998, Journal of the American Society of Nephrology : JASN.

[24]  K. S. Hall,et al.  Living donor kidney transplants: a biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  J. Nyengaard,et al.  Measurements of cortical interstitium in biopsies from human kidney grafts: how representative and how reproducible? , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  G. Nyberg,et al.  Chronic allograft nephropathy: biopsy findings and outcome , 2001 .

[27]  J. Feehally,et al.  Early measurement of interstitial fibrosis predicts long‐term renal function and graft survival in renal transplantation , 1996, The British journal of surgery.

[28]  A. Schwarz,et al.  Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. , 2005, Kidney international.

[29]  J. Chapman,et al.  Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology , 2004, Transplantation.

[30]  T. Paavonen,et al.  Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies. , 2003, Journal of the American Society of Nephrology : JASN.

[31]  R. Colvin,et al.  Banff '05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (‘CAN’) , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[32]  E. Thervet,et al.  Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. , 1998, Transplantation.

[33]  J. Chapman,et al.  EFFECT OF HISTOLOGICAL DAMAGE ON LONG-TERM KIDNEY TRANSPLANT OUTCOME , 2001, Transplantation.

[34]  R. Gans,et al.  Insulin resistance as putative cause of chronic renal transplant dysfunction. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  Joseph P Grande,et al.  Correlation of Quantitative Digital Image Analysis with the Glomerular Filtration Rate in Chronic Allograft Nephropathy , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  B. Ryffel,et al.  Histopathology of cyclosporine nephrotoxicity. , 1988, Transplantation proceedings.

[37]  Lars Pape,et al.  Computer-assisted quantification of fibrosis in chronic allograft nephropaty by picosirius red-staining: a new tool for predicting long-term graft function1 , 2003, Transplantation.

[38]  D. Heisey,et al.  The impact of hypoalbuminemia in kidney-pancreas transplant recipients. , 1999, Transplantation.

[39]  P. Grimm.  The protocol renal allograft biopsy: Has its time come? , 2004, Pediatric transplantation.

[40]  J. Chapman.  Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations. , 2005, Kidney international. Supplement.

[41]  P. Nickerson,et al.  Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. , 2003, Journal of the American Society of Nephrology : JASN.